Clinical Trial Update: Treatment of Male Pattern Baldness With Botulinum Toxin [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating botulinum toxin for androgenetic alopecia (male pattern baldness) has completed, reporting the study results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: The Crown Institute | Conditions: Male Pattern Baldness | Phase 2 | Status: COMPLETED